Urologix, Inc. (ULGX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2013 | -7.6 Million USD | -77.26% |
| 2012 | -4.29 Million USD | 8.58% |
| 2011 | -4.69 Million USD | -25.77% |
| 2010 | -3.73 Million USD | -72.11% |
| 2009 | -2.16 Million USD | 50.92% |
| 2008 | -4.41 Million USD | 70.34% |
| 2007 | -14.89 Million USD | -12.54% |
| 2006 | -13.23 Million USD | -340.94% |
| 2005 | 5.49 Million USD | 93.66% |
| 2004 | 2.83 Million USD | 341.9% |
| 2003 | 642 Thousand USD | 106.39% |
| 2002 | -10.04 Million USD | -508.6% |
| 2001 | -1.65 Million USD | 67.85% |
| 2000 | -5.13 Million USD | 27.65% |
| 1999 | -7.09 Million USD | 49.66% |
| 1998 | -14.1 Million USD | 6.0% |
| 1997 | -15 Million USD | -82.93% |
| 1996 | -8.2 Million USD | -7.89% |
| 1995 | -7.6 Million USD | -40.74% |
| 1994 | -5.4 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2014 Q2 | -357 Thousand USD | 18.31% |
| 2014 Q1 | -437 Thousand USD | 87.6% |
| 2014 Q3 | -349 Thousand USD | 2.24% |
| 2013 Q3 | -1.66 Million USD | -53.36% |
| 2013 Q4 | -3.52 Million USD | -111.84% |
| 2013 FY | -7.6 Million USD | -77.26% |
| 2013 Q1 | -1.33 Million USD | -6.98% |
| 2013 Q2 | -1.08 Million USD | 18.67% |
| 2012 Q1 | -1.06 Million USD | 12.66% |
| 2012 FY | -4.29 Million USD | 8.58% |
| 2012 Q2 | -970 Thousand USD | 9.26% |
| 2012 Q4 | -1.24 Million USD | -24.08% |
| 2012 Q3 | -1 Million USD | -3.61% |
| 2011 Q4 | -1.22 Million USD | -26.45% |
| 2011 Q2 | -1.11 Million USD | 19.15% |
| 2011 Q1 | -1.38 Million USD | -4.06% |
| 2011 FY | -4.69 Million USD | -25.77% |
| 2011 Q3 | -968 Thousand USD | 13.49% |
| 2010 FY | -3.73 Million USD | -72.11% |
| 2010 Q4 | -1.33 Million USD | -35.3% |
| 2010 Q3 | -983 Thousand USD | -38.06% |
| 2010 Q2 | -712 Thousand USD | -0.56% |
| 2010 Q1 | -708 Thousand USD | -13.83% |
| 2009 Q3 | -597 Thousand USD | -118.68% |
| 2009 FY | -2.16 Million USD | 50.92% |
| 2009 Q4 | -622 Thousand USD | -4.19% |
| 2009 Q2 | -273 Thousand USD | 59.68% |
| 2009 Q1 | -677 Thousand USD | 22.54% |
| 2008 Q2 | -1.06 Million USD | 16.17% |
| 2008 FY | -4.41 Million USD | 70.34% |
| 2008 Q4 | -874 Thousand USD | 27.23% |
| 2008 Q1 | -1.27 Million USD | 43.18% |
| 2008 Q3 | -1.2 Million USD | -12.45% |
| 2007 Q4 | -2.24 Million USD | -4.72% |
| 2007 Q3 | -2.14 Million USD | 78.84% |
| 2007 Q1 | -397 Thousand USD | 96.71% |
| 2007 Q2 | -10.11 Million USD | -2448.36% |
| 2007 FY | -14.89 Million USD | -12.54% |
| 2006 FY | -13.23 Million USD | -340.94% |
| 2006 Q4 | -12.08 Million USD | -1454.7% |
| 2006 Q3 | -777 Thousand USD | -628.57% |
| 2006 Q2 | 147 Thousand USD | 127.95% |
| 2006 Q1 | -526 Thousand USD | -111.28% |
| 2005 Q2 | 319 Thousand USD | 118.49% |
| 2005 Q1 | 146 Thousand USD | -70.92% |
| 2005 FY | 5.49 Million USD | 93.66% |
| 2005 Q3 | 364 Thousand USD | 14.11% |
| 2005 Q4 | 4.66 Million USD | 1181.59% |
| 2004 Q2 | 793 Thousand USD | 0.63% |
| 2004 Q1 | 788 Thousand USD | -5.85% |
| 2004 Q4 | 502 Thousand USD | -33.42% |
| 2004 FY | 2.83 Million USD | 341.9% |
| 2004 Q3 | 754 Thousand USD | -4.92% |
| 2003 FY | 642 Thousand USD | 106.39% |
| 2003 Q1 | -490 Thousand USD | 86.9% |
| 2003 Q2 | -207 Thousand USD | 57.76% |
| 2003 Q3 | 502 Thousand USD | 342.51% |
| 2003 Q4 | 837 Thousand USD | 66.73% |
| 2002 Q2 | -2.49 Million USD | -42.29% |
| 2002 FY | -10.04 Million USD | -508.6% |
| 2002 Q4 | -3.74 Million USD | -80.85% |
| 2002 Q1 | -1.75 Million USD | -395.75% |
| 2002 Q3 | -2.06 Million USD | 16.95% |
| 2001 Q2 | -470 Thousand USD | 35.88% |
| 2001 Q3 | -95 Thousand USD | 79.79% |
| 2001 Q4 | -353 Thousand USD | -271.58% |
| 2001 FY | -1.65 Million USD | 67.85% |
| 2001 Q1 | -733 Thousand USD | 14.17% |
| 2000 Q2 | -1.6 Million USD | -10.07% |
| 2000 Q4 | -854 Thousand USD | 29.65% |
| 2000 FY | -5.13 Million USD | 27.65% |
| 2000 Q1 | -1.46 Million USD | 10.46% |
| 2000 Q3 | -1.21 Million USD | 24.46% |
| 1999 Q4 | -1.63 Million USD | -0.46% |
| 1999 Q3 | -1.62 Million USD | 9.83% |
| 1999 Q1 | -2 Million USD | 23.08% |
| 1999 FY | -7.09 Million USD | 49.66% |
| 1999 Q2 | -1.8 Million USD | 10.0% |
| 1998 Q2 | -2.9 Million USD | 53.23% |
| 1998 Q4 | -2.6 Million USD | -8.33% |
| 1998 Q3 | -2.4 Million USD | 17.24% |
| 1998 Q1 | -6.2 Million USD | 15.07% |
| 1998 FY | -14.1 Million USD | 6.0% |
| 1997 Q1 | -2 Million USD | 31.03% |
| 1997 Q3 | -3.5 Million USD | -66.67% |
| 1997 Q4 | -7.3 Million USD | -108.57% |
| 1997 FY | -15 Million USD | -82.93% |
| 1997 Q2 | -2.1 Million USD | -5.0% |
| 1996 Q3 | -1.9 Million USD | -18.75% |
| 1996 Q4 | -2.9 Million USD | -52.63% |
| 1996 FY | -8.2 Million USD | -7.89% |
| 1996 Q1 | -1.8 Million USD | 5.26% |
| 1996 Q2 | -1.6 Million USD | 11.11% |
| 1995 FY | -7.6 Million USD | -40.74% |
| 1995 Q3 | -1.9 Million USD | 0.0% |
| 1995 Q1 | -1.9 Million USD | -58.33% |
| 1995 Q2 | -1.9 Million USD | 0.0% |
| 1995 Q4 | -1.9 Million USD | 0.0% |
| 1994 Q2 | -1.4 Million USD | 0.0% |
| 1994 Q4 | -1.2 Million USD | 14.29% |
| 1994 FY | -5.4 Million USD | 0.0% |
| 1994 Q3 | -1.4 Million USD | 0.0% |
| 1994 Q1 | -1.4 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| CVR Medical Corp. | - USD | Infinity% |
| BioElectronics Corporation | -722.81 Thousand USD | -952.556% |
| IR-Med Inc. | -4.9 Million USD | -54.981% |
| Polarean Imaging plc | -11.88 Million USD | 35.985% |
| Medical Supply International USA, Inc. | 394.84 Thousand USD | 2026.856% |
| Avitar, Inc. | -2.25 Million USD | -236.692% |
| AVITA Medical, Inc. | -39.16 Million USD | 80.576% |
| Manhattan Scientifics, Inc. | -1.16 Million USD | -553.047% |
| Össur hf. | 58.38 Million USD | 113.03% |
| Zecotek Photonics Inc. | -3.51 Million USD | -116.199% |
| QHSLab, Inc. | -468.36 Thousand USD | -1524.385% |
| Wellstar International, Inc. | -3.1 Million USD | -144.751% |
| Össur hf. | 58.38 Million USD | 113.03% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | 2.35 Million USD | 423.469% |
| Escalon Medical Corp. | -125.26 Thousand USD | -5973.718% |
| Aurora Spine Corporation | -1.68 Million USD | -352.705% |
| BrainsWay Ltd. | -4.19 Million USD | -81.272% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | -11.49 Million USD | 33.822% |
| Hamilton Thorne Ltd. | -607.02 Thousand USD | -1153.332% |
| Vivos Inc. | -2.89 Million USD | -162.82% |
| MicroPort Scientific Corporation | -477.62 Million USD | 98.407% |
| Kelyniam Global, Inc. | -218.47 Thousand USD | -3382.384% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -327.936% |
| CYduct Diagnostics, Inc. | -418.03 Thousand USD | -1719.952% |
| Nanomix Corporation | -12.33 Million USD | 38.312% |
| Theraclion SA | -3.67 Million USD | -107.02% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | -752.98 Thousand USD | -910.384% |
| Positron Corporation | -1.63 Million USD | -364.27% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.64 Million USD | -188.046% |
| Lombard Medical, Inc. | -31.03 Million USD | 75.486% |
| ALR Technologies Inc. | -11.89 Million USD | 36.049% |
| Stratec SE | 14.42 Million USD | 152.738% |
| Vycor Medical, Inc. | -69.69 Thousand USD | -10816.761% |
| Heart Tronics, Inc. | -13.32 Million USD | 42.914% |
| Nu-Med Plus, Inc. | -125.52 Thousand USD | -5960.896% |
| Perimeter Medical Imaging AI, Inc. | -14.03 Million USD | 45.797% |
| SANUWAVE Health, Inc. | -25.8 Million USD | 70.52% |
| VMS Rehab Systems, Inc. | 46.44 USD | 16382528.941% |
| Guided Therapeutics, Inc. | -3.48 Million USD | -118.057% |
| Ingen Technologies, Inc. | -5.06 Million USD | -50.312% |
| Odyssey Group International, Inc. | -905.77 Thousand USD | -739.947% |
| United American Healthcare Corporation | 723 Thousand USD | 1152.282% |
| ECGI Holdings, Inc. | -3.61 Million USD | -110.696% |
| Capital Group Holdings, Inc. | -658.02 Thousand USD | -1056.189% |
| ADM Tronics Unlimited, Inc. | -716.85 Thousand USD | -961.308% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.69 Million USD | -349.167% |
| Nexeon MedSystems Inc. | -2.17 Million USD | -249.369% |
| SS Innovations International, Inc. | -20.94 Million USD | 63.671% |
| Qualis Innovations, Inc. | -805.02 Thousand USD | -845.069% |
| Smith & Nephew plc | 263 Million USD | 102.893% |
| NIOX Group Plc | 13.64 Million USD | 155.775% |
| Fuse Medical, Inc. | 1.45 Million USD | 621.109% |
| Broncus Holding Corporation | -28.09 Million USD | 72.917% |
| Brain Scientific Inc. | -12.34 Million USD | 38.366% |
| Pressure BioSciences, Inc. | -29.31 Million USD | 74.047% |
| Health Logic Interactive Inc. | -160.24 Thousand USD | -4647.641% |